| Welcure Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524661 |
NSE Symbol : - |
P/E(TTM) : 1.93 |
|
ISIN Demat : INE331C01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.28 |
|
Book Value(₹) : 1.09 |
Market Cap(₹Cr) : 66.74 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 65.62 | 299.91 | 21.21 | 0.88 | 24.55 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 65.62 | 299.91 | 21.21 | 0.88 | 24.55 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 1.91 | 0.00 | 0.00 | 0.00 |
| Total Income | 65.62 | 299.91 | 23.12 | 0.88 | 24.55 | 0.00 |
| Total Expenditure | 54.25 | 268.77 | 20.58 | 0.79 | 22.71 | 0.34 |
| PBIDT | 11.37 | 31.14 | 2.55 | 0.09 | 1.84 | -0.34 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 11.37 | 31.14 | 2.55 | 0.09 | 1.84 | -0.34 |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Tax | 2.86 | 7.84 | 0.00 | 0.05 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 8.50 | 23.30 | 2.54 | 0.04 | 1.84 | -0.34 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 8.50 | 23.30 | 2.54 | 0.04 | 1.84 | -0.34 |
| EPS (Unit Curr.) | 0.76 | 2.07 | 0.33 | 0.04 | 0.16 | -0.26 |
| EPS (Adj) (Unit Curr.) | 0.07 | 0.19 | 0.03 | 0.00 | 0.01 | -0.02 |
| Calculated EPS (Unit Curr.) | 0.76 | 2.07 | 0.23 | 0.03 | 0.16 | -0.26 |
| Calculated EPS (Adj) (Unit Curr.) | 0.07 | 0.19 | 0.02 | 0.00 | 0.01 | -0.02 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.03 | 8.29 | 0.90 | 0.12 | 0.65 | -1.03 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.28 | 0.76 | 0.08 | 0.01 | 0.06 | -0.09 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 112.44 | 112.36 | 112.44 | 13.44 | 112.44 | 13.44 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.33 | 10.38 | 12.02 | 10.23 | 7.49 | 0.00 |
| PBDTM(%) | 17.33 | 10.38 | 12.02 | 10.23 | 7.49 | 0.00 |
| PATM(%) | 12.95 | 7.77 | 11.98 | 4.55 | 7.49 | 0.00 |